Intensive adjuvant chemotherapy for breast cancer
Explore this paper's citation graph
- Type
- article
- Published
- 1999-10-25
- Cited by
- 0
- References
- 7
- OpenAlex
- https://openalex.org/W2008540335
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:37029319
Keywords
Medicine, Surgical oncology, Breast cancer, Oncology, Adjuvant chemotherapy
References
- Tamoxifen for early breast cancer: an overview of the randomised trials
- Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
- Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.
- Randomised controlled trial of high dose chemotherapy (HD-CNVp) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer
- Mathematical modelling of tumour response in primary breast cancer.
- Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
- Overall survival (OS) advantage to simultaneous chemotherapy plus humanised anti HER2 monoclonal antibody Herceptin in HER2; Overexpressing metastatic breast cancer.
Cited by
No citing papers recorded for this paper.
Related papers
- Abstracts exchange: European Journal of Surgical Oncology
- ASO Author Reflections: Investigating the Relationship Between Patient Primary Language and Surgical Oncology Outcomes
- ASO Visual Abstract: Application and Match Rates in the Complex General Surgical Oncology Match
- Controversies in Gynaecologic Oncology
- Society of Surgical Oncology SSO 2023 - International Conference on Surgical Cancer Care
- Society of Surgical Oncology 71st Annual Cancer Symposium
- Global Forum of Cancer Surgeons: Support for the Brazilian Society of Surgical Oncology Journey towards Implementation of Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy in Brazil
- ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers—Does One Size Fit All?
- The Role of Serum CEA as a Prognostic Indicator in Stage II and III Breast Cancer Patients Treated With Adjuvant Chemotherapy